NDC 0054-4859-51 - Triazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0054-4859
- Requested NDC
- 0054-4859-51
- Package NDCs from labels
- 0054-4859-25, 0054-4859-29, 0054-4859-51
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2024-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triazolam - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2024-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Triazolam - Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | 2024-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Triazolam - A-S Medication Solutions | A-S Medication Solutions | 2023-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Triazolam - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| TRIAZOLAM Tablets, USP 0.25 mg CIV | Aphena Pharma Solutions - Tennessee, Inc. | 2012-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Triazolam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-12-01 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0054-4859-25 | EA - Each | 0054-4859 | 19001a2c-f632-4ead-b143-aa91f6c88e88 | 1 | 2018-12-13 |
| 0054-4859-29 | EA - Each | 0054-4859 | 633df502-7880-4520-b41d-8c99dcb1e66a | 1 | 2012-07-24 |
| 0054-4859-51 | EA - Each | 0054-4859 | 53f18499-7cad-42c1-8bfe-c4bf426b7e82 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 4180a35b-cc50-46ae-a100-99bb218c10ff | 2026-09-09 | Warnings | F05Q2T2JA0 |
| Kroger Stool Softener Fruit Punch | DOCUSATE SODIUM | KROGER COMPANY | b86f8f3d-594e-466c-854a-b8bff9f7a0b8 | 2026-09-02 | Warnings | F05Q2T2JA0 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | Preferred Pharmaceuticals, Inc. | b25b8a28-5e00-4a20-9ca3-7ed494fc4540 | 2026-09-01 | Warnings | F05Q2T2JA0 |
| HyVee Senna S | DOCUSATE SODIUM, SENNOSIDES | HyVee Inc | 4982b9c6-ed0e-24da-e063-6394a90a147f | 2026-08-24 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | ccec364a-3135-4a5d-b4b0-86b832387b4e | 2026-08-24 | Warnings | F05Q2T2JA0 |
| Colace | DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | a1591da0-a1a9-9583-3cf5-788b8fee3814 | 2026-08-24 | F05Q2T2JA0 | |
| HyVee Senna S | DOCUSATE SODIUM, SENNOSIDES | HyVee Inc | 49837b2c-492f-2fed-e063-6294a90aaa24 | 2026-08-21 | Warnings | F05Q2T2JA0 |
| Senokot-S | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | c24cdc5e-62e0-41a6-8afb-512202a569f4 | 2026-08-21 | Warnings | F05Q2T2JA0 |
| Foster and Thrive Senna-S Sennosides and Docusate Sodium Laxative and Stool Softener | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Strategic Sourcing Services LLC | 5966ff80-7be2-788a-e063-6294a90ab4f3 | 2026-08-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | Safeway, Inc. | ae2c7300-f9c4-43b5-9f8e-30f2e7d17635 | 2026-08-19 | Warnings | F05Q2T2JA0 |
| CVS Stool Softener Fruit Punch | DOCUSATE SODIUM | CVS PHARMACY, INC | 0e6900d6-7dc9-47d6-a006-1695feb8d5a5 | 2026-08-17 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 306fd12b-ed60-40dc-a5be-2dc394bd29d2 | 2026-08-17 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | Morepen Bio Inc | 562d1b9a-09d8-92fc-e063-6394a90a1993 | 2026-08-14 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | f4671579-aed0-4f93-ab83-248e0d72b5b0 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | Aldama Pharmaceuticals, Inc | 492b6d37-47cf-3a28-e063-6294a90a2a18 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Shield Pharmaceuticals Corp | 0be906d8-3db5-4218-bbdf-f1d126007990 | 2026-08-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 4e97dd60-96e3-4b51-b614-c62480af1919 | 2026-08-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 098d2377-0019-45fe-b995-700b1b1241c4 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Docusate Sodium softgels 50mg (Dye Free) | DOCUSATE SODIUM | CVS Pharmacy | 273ea95f-3c9c-98e8-e063-6294a90a2135 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| MiraSOFT Stool Softener | DOCUSATE SODIUM | Bayer HealthCare LLC. | 5851f15f-8add-559f-e063-6394a90a7b7d | 2026-08-05 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.